Explore /
Poster
/ NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).

Authors

Eleftherios P. Mamounas

NSABP/NRG Oncology, and UF Cancer Center at Orlando Health, Orlando, FL

Eleftherios P. Mamounas , Hanna Bandos , Julia R. White , Thomas B. Julian , Atif J. Khan , Simona Flora Shaitelman , Mylin Ann Torres , Frank Vicini , Patricia A. Ganz , Susan Ann McCloskey , Soonmyung Paik , Nilendu Gupta , X. Allen Li , Dominic J. DiCostanzo , Joseph P. Costantino , Walter John Curran Jr., Norman Wolmark

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Local Therapy

Clinical Trial Registration Number

NCT01872975

Citation

J Clin Oncol 34, 2016 (suppl; abstr TPS1097)

DOI

10.1200/JCO.2016.34.15_suppl.TPS1097

Abstract #

TPS1097

Poster Bd #

201b

Abstract Disclosures

Similar Posters

Poster

2018 ASCO Annual Meeting